ID

13021

Descripción

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00275015

Link

https://clinicaltrials.gov/show/NCT00275015

Palabras clave

  1. 12/1/16 12/1/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

12 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia NCT00275015

Eligibility Leukemia NCT00275015

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Criteria
Descripción

Criteria

patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
Descripción

CLL

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023434
binet stage b or c disease
Descripción

binet stage

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1511118
binet stage a disease and at high risk for disease progression, defined as the following:
Descripción

binet stage a disease and at high risk for disease progression

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1511118
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Descripción

non-nodular marrow infiltration or lymphocyte doubling time < 12 months

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3854434
UMLS CUI [2]
C2986483
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
Descripción

thymidine kinase, ß-2-microglobulin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040078
UMLS CUI [2]
C0005149
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Descripción

polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0887928
ecog performance status 0-1
Descripción

ecog performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
no concurrent disease resulting in major organ dysfunction
Descripción

no concurrent disease resulting in major organ dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Descripción

no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025241
UMLS CUI [2]
C0011777
UMLS CUI [3]
C0007257
UMLS CUI [4]
C0010711
UMLS CUI [5]
C0015133
no more than 1 prior chemotherapy regimen
Descripción

no more than 1 prior chemotherapy regimen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
no prior chemotherapy regimen longer than 6 months in duration
Descripción

no prior chemotherapy regimen longer than 6 months in duration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920

Similar models

Eligibility Leukemia NCT00275015

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00275015
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
CLL
Item
patients with chronic lymphocytic leukemia, meeting 1 of the following criteria:
boolean
C0023434 (UMLS CUI [1])
binet stage
Item
binet stage b or c disease
boolean
C1511118 (UMLS CUI [1])
binet stage a disease and at high risk for disease progression
Item
binet stage a disease and at high risk for disease progression, defined as the following:
boolean
C1511118 (UMLS CUI [1])
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
Item
non-nodular marrow infiltration or lymphocyte doubling time < 12 months
boolean
C3854434 (UMLS CUI [1])
C2986483 (UMLS CUI [2])
thymidine kinase, ß-2-microglobulin
Item
thymidine kinase > 7.0 u/l or ß-2-microglobulin > 3.5 mg/l
boolean
C0040078 (UMLS CUI [1])
C0005149 (UMLS CUI [2])
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
Item
polymerase chain reaction-amplifiable clonal cdriii rearrangement of the igv_h
boolean
C0887928 (UMLS CUI [1])
ecog performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
no concurrent disease resulting in major organ dysfunction
Item
no concurrent disease resulting in major organ dysfunction
boolean
C0009488 (UMLS CUI [1])
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
Item
no prior combination therapy comprising melphalan, dexamethasone, carmustine, cytarabine, and etoposide (dexa-beam)
boolean
C0025241 (UMLS CUI [1])
C0011777 (UMLS CUI [2])
C0007257 (UMLS CUI [3])
C0010711 (UMLS CUI [4])
C0015133 (UMLS CUI [5])
no more than 1 prior chemotherapy regimen
Item
no more than 1 prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
no prior chemotherapy regimen longer than 6 months in duration
Item
no prior chemotherapy regimen longer than 6 months in duration
boolean
C0392920 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial